Edgewise Therapeutics, Inc. · NASDAQ:EWTX
Russell Alan J sold 200,000 Edgewise Therapeutics, Inc. shares (Form 4)
Traded Jul 1, 2026 · Filed Jul 2, 2026
On Jul 1, 2026, Russell Alan J (Director, Chief Scientific Officer) sold 200,000 Edgewise Therapeutics, Inc. shares at US$39.41 for US$7.88M under a trading plan, leaving 24,555 shares. Filed Jul 2, 2026 (Form 4).
- Sold
- 200,000 shares
- Price
- US$39.41
- Value
- US$7.88M
- Holding after
- 24,555 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Option exercise | 130,352 | US$0.45 | 154,907 | Direct |
| Jul 1, 2026 | Common Stock | Option exercise | 69,648 | US$0.18 | 224,555 | Direct |
| Jul 1, 2026 | Common Stock | Sale | 130,352 | US$39.41 | 94,203 | Direct |
| Jul 1, 2026 | Common Stock | Sale | 69,648 | US$39.41 | 24,555 | Direct |
Source
Related
- Edgewise Therapeutics, Inc.
- Russell Alan J
- Edgewise Therapeutics, Inc. shareholders
- Form 4 · Russell Alan J · Aug 14, 2026
- Form 4 · Fox Jonathan C · Oct 2, 2026
- Form 4 · Donovan Joanne M. · Aug 14, 2026
- Form 4 · Moore John R · Aug 14, 2026
- Form 4 · Derakhshan Behrad · Aug 14, 2026
- Form 4 · Koch Kevin · Aug 14, 2026